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Although it has been suspected that ~nfants born of drugaddicted mothers have an increased incidence of infections, it has been unclear whether this is due to social factors, increased exposure to infectious agents, or effects of the addicting drugs. Three groups of infants were followed through one year of age, and the incidence of infection was evaluated. Group A infants (N=21) were delivered to women w h o used heroin intravenously, Group B infants (N=15) to women w h o abused nonopiate drugs orally and Group C infants (N=15) to women w~t h no evidence of drug use. There was no difference In the three groups as to maternal age, education, race, income or cigarette use. More patients in Group A had an illness during the first year of life The mother of a third infant, MF, has AIDS, likely acquired from her i.v. drug abusing husband. This child has lymphoid interstitial pneumonia and sinusitis. Laboratory evaluation of these infants revealed reversed T he1per:suppressor ratios, decreased lymphoprol iferative responses to mi togens and hyperimunoglobulinemia G and A. JP's and PB's serum IgG levels declined as their disease progressed. In addition, JP has absent IgG2, PB had absent IgG3 and MF had absent IgG2 and IgG4. Other IgG subclasses were normal. In the 4 adult subjects, total IgG levels were increased and IgG subclasses were normal to increased.
The finding of selective IgG subclass deficiencies in PAIDS is consistent with the improvement seen in some of these patients following Ig replacement therapy. The normal IgG subclass values noted in the adult AIDS patients in association with a lack of characteristic infections indicate that Ig would not be of benefit in these ~atients. CVI in childhood is not a well described entity. We have followed 6 children (2 males and 4 females) with this disease who have also had multiple severe, autoimmune disorders that have overshadowed infections as clinical problems. These children have all had onset of disease before 5 years of age and all have had severe growth failure. The autoimmune disorders have included ITP with autoimmune hemolytic anemia (3/6), diarrhea, malabsorption or gastritis (5/6), JRA (2/6), parotitis (2/6), chronic active hepatitis (216) and Guillian ~arr; Syndrome (216). All have had hypogammaglobulinemia. T and B cells have been present in the peripheral circulation, although in some cases in reduced numbers. Delayed hypersensitivity skin tests and proliferative responses to mitogens have been normal. T cell subsets, done in 4 of the patients, demonstrated an increased ratio of T helpers to T suppressors (T41T8); 3.2 + 0.6 vs. In the airway, gastrointestinal tract, renal parenchyma, and during some clinical situations, basophils and mast cells are exposed to a hyperosmolar milieu. We have shown that hyperosmolar stimuli release pharmacologically active mediators and that the process is distinct from IgE-dependent release. Significant mast cell histamine release occurs at just above physiologic levels (360 m0sm) and reaches a maximum of 12'1% at 770 m0sm; release from basophils is significant at 560 mOsm and reaches a maximum of 45+7% at 1020 m0sm. Activation of mast cells is dependent on extracellular ~a * but maximal release from basophils is only partially reduced in ~a * free buffers. Hyperosmolar buffers also increase IgE-dependent histamine release synergistically (mast cells: 460 mOsm 7 ' 1 % release; 1 pg/ml anti IgE 7'1%; both 27'4%). Prostaglandin D2 (PGD2) production from mast cells at 770 mOsm (69 pg/100 ~1 ) was not different from unstimulated cells (83 pg/100 u1) despite significant histamine release (16% vs. 4% control). Furthermore, IgE-dependent PGD2 production (264 pg1100 u1) was suppressed (99 pg/100 pl) in hyperosmolar buffers (p<0.01).
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The distinctive activation by hyperosmolarity and its interaction with IgEdependent activation may have important implications for airway physiology, and the management of radiocontrast anaphylactoid reactions and clinical hyperosmolarity syndromes.
